CAPTRUST Financial Advisors
SILK

CAPTRUST Financial Advisors’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

CAPTRUST Financial Advisors’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-257
Closed -$9K – 4259
2022
Q2 		$9K Buy
257
+118
+85% +$4.29K ﹤0.01% 3827
2022
Q1 		$6K Buy
139
+116
+504% +$4.08K ﹤0.01% 4097
2021
Q4 		$1K Buy
23
+6
+35% +$300 ﹤0.01% 4656
2021
Q3 		$1K Buy
17
+5
+42% +$262 ﹤0.01% 4516
2021
Q2 		$1K Hold
12
– – ﹤0.01% 4407
2021
Q1 		$1K Buy
+12
New +$667 ﹤0.01% 4262

Other funds holding SILK

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

CAPTRUST Financial Advisors's SILK Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2022, closing a stake of 257 shares — an estimated $9K sold.

CAPTRUST Financial Advisors first reported a position in SILK in Q1 2021 and held it in 6 quarters. The position peaked at $9K in Q2 2022. 147 funds tracked by Wall St. Rank hold SILK as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 257 Silk Road Medical, Inc. Common Stock shares in Q3 2022, an estimated $9K.
  • CAPTRUST Financial Advisors first reported a position in Silk Road Medical, Inc. Common Stock in Q1 2021 and held it in 6 quarters.
  • CAPTRUST Financial Advisors's Silk Road Medical, Inc. Common Stock position peaked at $9K in Q2 2022.
  • 147 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.